Kenneth N Ross

Title: Kenneth N. Ross: Innovator in Prostate Cancer Diagnosis

Introduction

Kenneth N. Ross is a notable inventor based in Boston, MA (US), recognized for his contributions to the field of prostate cancer diagnosis and treatment. With a focus on innovative methods for identifying and prognosing prostate cancer, he has made significant strides in medical research.

Latest Patents

Kenneth N. Ross holds 2 patents related to prostate cancer diagnosis and outcome prediction through expression analysis. His latest patents describe methods for identifying prostate cancer, prognosing and diagnosing the disease, and identifying compounds that modulate prostate cancer development. Additionally, he has developed methods for determining the efficacy of prostate cancer therapies and oligonucleotide microarrays containing probes for genes involved in prostate cancer development.

Career Highlights

Throughout his career, Kenneth has worked with prestigious institutions such as the Whitehead Institute for Biomedical Research and Dana-Farber Cancer Institute Inc. His work has been instrumental in advancing the understanding and treatment of prostate cancer.

Collaborations

Kenneth has collaborated with esteemed colleagues, including Todd R. Golub and Phillip G. Febbo, contributing to a rich environment of innovation and research in cancer diagnostics.

Conclusion

Kenneth N. Ross's work in prostate cancer diagnosis exemplifies the impact of innovative research on medical science. His patents and collaborations continue to influence the field, paving the way for improved diagnostic methods and therapies.